Display options
Cite
Kayser S, Rahmé R, Martínez-Cuadrón D, et al. Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia. 2021;35(12):3631doi: 10.1038/s41375-021-01358-3.
Kayser, S., Rahmé, R., Martínez-Cuadrón, D., Ghiaur, G., Thomas, X., Sobas, M., Guerci-Bresler, A., Garrido, A., Pigneux, A., Gil, C., Raffoux, E., Tormo, M., Vey, N., de la Serna, J., Salamero, O., Lengfelder, E., Levis, M. J., Fenaux, P., Sanz, M. A., Platzbecker, U., Schlenk, R. F., Adès, L., & Montesinos, P. (2021). Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia, 35(12), 3631. https://doi.org/10.1038/s41375-021-01358-3
Kayser, Sabine, et al. "Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study." Leukemia vol. 35,12 (2021): 3631. doi: https://doi.org/10.1038/s41375-021-01358-3
Kayser S, Rahmé R, Martínez-Cuadrón D, Ghiaur G, Thomas X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis MJ, Fenaux P, Sanz MA, Platzbecker U, Schlenk RF, Adès L, Montesinos P. Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia. 2021 Dec;35(12):3631. doi: 10.1038/s41375-021-01358-3. PMID: 34785795; PMCID: PMC8632664.
Copy Download .nbib Format: NLM
Share it on

Leukemia. 2021 Dec;35(12):3631. doi: 10.1038/s41375-021-01358-3.

Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.

Leukemia

Sabine Kayser, Ramy Rahmé, David Martínez-Cuadrón, Gabriel Ghiaur, Xavier Thomas, Marta Sobas, Agnes Guerci-Bresler, Ana Garrido, Arnaud Pigneux, Cristina Gil, Emmanuel Raffoux, Mar Tormo, Norbert Vey, Javier de la Serna, Olga Salamero, Eva Lengfelder, Mark J Levis, Pierre Fenaux, Miguel A Sanz, Uwe Platzbecker, Richard F Schlenk, Lionel Adès, Pau Montesinos

Affiliations

  1. Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany. [email protected].
  2. German Cancer Research Center (DKFZ), Heidelberg, Germany. [email protected].
  3. Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. [email protected].
  4. Hôpital Saint Louis, Université Paris Diderot, Paris, France.
  5. Hematology Department, Hospital Universitari i Politècnic, València, Spain.
  6. CIBERONC, Instituto Carlos III, Madrid, Spain.
  7. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  8. Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Lyon, France.
  9. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  10. Department of Hematology, Nancy University Hospital, Nancy, France.
  11. Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  12. Department of Hematology, Bordeaux University Hospital, Bordeaux, France.
  13. Hospital General, Alicante, Spain.
  14. Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
  15. Institut Paoli Calmette, Marseille, France.
  16. Hospital 12 de Octubre, Madrid, Spain.
  17. Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  18. Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  19. Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
  20. Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  21. NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.

PMID: 34785795 PMCID: PMC8632664 DOI: 10.1038/s41375-021-01358-3

[No abstract available.]

Publication Types